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BY-NC-ND license (http://creativecomBackground/Purpose: Interleukin-33 (IL-33) could play an important role in the pathogenesis of
angiostrongylosis. However, the role of IL-33/ST2 pathway in this parasitic infection is uncer-
tain.
Methods: C57BL/six mice were each infected with 35 Angiostrongylus cantonensis larvae. One
group of mice received an intraperitoneal injection of anti-ST2 monoclonal antibody (mAb;
50 mg) 3 days postinfection and subsequent booster shots of the same dose at 5-day intervals.
Blood samples from each group were collected every week for assays.
Results: The level of IL-5 significantly decreased in the mAb-treated group, and the infiltration
of eosinophils in the meninges was also significantly reduced.
Conclusion: The IL-33/ST2 axis may play a crucial role in the pathogenesis of angiostrongylosis
and the results of this study could be useful for the development of strategies to reduce the
neurological damage caused by this parasitic infection.
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Angiostrongylus cantonensis, the rat lungworm, is a com-
mon causative agent of human eosinophilic meningitis or
eosinophilic meningoencephalitis in Taiwan.1 The parasitic
disease is also endemic to mainland China, Japan, some
Pacific islands, and Southeast Asia.2,3by Elsevier Taiwan LLC. This is an open access article under the CC
).
92 C.-C. Chuang et al.Humans contract this parasitic disease by ingesting
infective third-stage larvae (L3) that are found in raw or
undercooked mollusks, which are the intermediate hosts
for A. cantonensis. The ingested larvae penetrate into
blood vessels in the intestinal tract and are carried to the
central nervous system, but are unable to migrate to the
lungs, as they do in rats. Most of the larvae develop into
young adults (L5) and then die shortly after reaching the
subarachnoid space, and hence do not complete the
developmental cycle.
When nonpermissive hosts, such as mice, are infected
with A. cantonensis, the immune response is primarily of
the Th2-type, including eosinophilia, increased immuno-
globulin E (IgE) antibody levels in the blood and cerebro-
spinal fluid, and the expression of Th2-type cytokines,
especially interleukin-5 (IL-5), IL-4, and IL-33.4e8
In A. cantonensis-infected mice, eosinophils appear to
release some granules that are able to kill the larvae, but
some cytotoxic proteins, such as eosinophil protein X and
eosinophil cationic protein, can damage the nervous tissues
of the host.9,10 In addition to mechanical injuries caused by
the migrating larvae, the proteins produced during eosin-
ophil infiltration and degranulation may be important fac-
tors that contribute to the immunopathology of
angiostrongylosis.6,10e12
Eosinophils act as immunoregulatory cells and are able
to produce many types of cytokines;13,14 however, the
mechanisms that regulate the biological function of these
cells are uncertain. It has been shown that several factors
could enhance the survival and/or the functions of mature
eosinophils, such as IL-5, IL-13, and granulocyte-
macrophage colony-stimulating factor.15 IL-5 is an impor-
tant stimulant for eosinophil, with functions that include
the promotion of degranulation and superoxide production.
IL-5 also synergises with various stimulating factors to in-
crease eosinophil progenitor production and eosinophil
expansion.12,16,17 Specific inhibitors of IL-5, such as the
anti-IL-5 monoclonal antibody (mAb), were able to atten-
uate eosinophil-associated inflammation.18,19
IL-33 belongs to the IL-1 family and has been shown to be
a promoter of Th2-type immune response and systemic
inflammation both in vivo and in vitro.20,21 In a study of
patients with asthma, IL-33 induced production of Th2-type
cytokines and was associated with mucus overproduction
and goblet cell hypertrophy in the lungs and the gastroin-
testinal tract. Furthermore, the increased expression of
this cytokine may be a novel inflammatory marker of
asthma.22 In addition, blockage of IL-33 by anti-IL-33 mAb
inhibits airway inflammation in an animal model. It is
demonstrated that IL-33 mediated the expressions of IL-5
and IL-13 in A. cantonensis-infected mice. Blockage of IL-
33 by anti-IL-33 mAb inhibits IL-5 expression in animal
models.23 IL-33 could play an important role in the patho-
genesis of angiostrongylosis and also provide a new thera-
peutic target for this parasitic disease.
IL-33 has a variety of effects on inflammatory cells
through the ST2 receptor.20 The binding of IL-33 to the ST2
receptor activates inflammatory cells through the nuclear
factor-kB and mitogen-activated protein kinases pathways
and induces the expression of Th2-type cytokines. Blockage
of IL-33 signaling by a soluble ST2 protein or anti-ST2 mAb
inhibits the immune response of asthma in mice.24,25For elucidating the role of IL-33/ST2 pathway in the
pathogenesis of angiostrongylosis, in this study, mice were
experimentally infected with larvae of A. cantonensis and
received injections of anti-ST2 mAb. The effects of anti-ST2
mAb were assessed by pathological examination and by
measuring eosinophil percentage and the levels of IgE and
cytokines in the peripheral circulation.Materials and methods
Animals
A. cantonensis was maintained in the laboratory using male
Wistar rats (150 g/body weight when first infected) as the
final host and the hermaphroditic freshwater snail Bio-
mphalaria glabrata as the intermediate host. Male C57BL/
six mice (20 g/body weight) were used as the nonpermissive
host in this study. The infective larvae (L3) were collected
from experimentally infected snails.
The rats and mice were specified as pathogen free and
were all purchased from the laboratory of the Animal
Centre at the National Taiwan University College of Medi-
cine (Taipei, Taiwan). Rats and mice were housed in
accordance with the institutional guidelines. The experi-
ments in this study were previously reviewed by an animal
ethics committee. During the experimental period, all mice
survived, and the gain in body weight of the mice in the
normal control, infected, and treatment groups was similar.Treatments
The mice were randomly divided into four groups. Each
group contained 10 mice for blood collection and 12 mice
for pathological examination. The four groups included a
noninfected group, an A. cantonensis-infected group, and
anti-ST2 mAb-injected groups with or without infection.
In the A. cantonensis-infected groups, each mouse was
orally infected with 35 infective larvae and was later
euthanized by anesthesia. In the injected groups, the mice
were injected with anti-ST2 mAb (50 mg in 0.1 mL of
phosphate-buffered saline; R&D Systems Inc; USA) intra-
peritoneally 3 days postinfection (dpi) and subsequently
injected with the same dose on Day 8, Day 13, Day 18, Day
23, Day 28, and Day 33. Blood samples from all mice were
collected from the tail vein every week for thin blood smear
and serum collection. The serum samples from each group
were pooled for the cytokine and IgE assays. The brains of
infected mice were removed for pathological examinations.Cytokine and IgE assays
The levels of cytokines and IgE in sera were determined
with enzyme-linked immunosorbent assay (ELISA) and Ac-
tivity Assay kits (R&D Systems Inc) and a mouse IgE ELISA kit
(Shibayagi Co., Ltd., Japan) according to the manufac-
turer’s instructions by two independent experiments.
Approximately 50 mL serum sample was used in each test.
The sensitivities of the kits were <2 pg/mL for IL-4 and
interferon-g (IFN-g), and <7 pg/mL for IL-5.
The role of anti-ST2 antibody in angiostrongylosis 93Pathological examinations
At 14 dpi, 21 dpi, 28 dpi, and 35 dpi, three of the infected
mice in each group were sacrificed. The brains of mice were
removed and fixed immediately in 10% (vol/vol) neutral
formalin. The brain samples were embedded in paraffin
wax and cut into 4e5-mm sections. The sections were pre-
pared from the frontal lobe, the central portion of the
cerebrum, the mesencephalon, and the medul-
laecerebellum, and were stained with hematoxylin and
eosin.6 At least 10 fields were observed from each section
under a light microscope at low (100) and high power
(400).
Statistical analysis
Results were shown as mean  standard deviation. Statis-
tical significance was assessed by Student t test to deter-
mine significance. A p value <0.01 was taken to be
significant.
Results
Eosinophil percentage in differential white blood
cell counts
The differential cell count of white blood cells in each
group was estimated every week with a thin blood smear
after the infection (Fig. 1). In noninfected mice, there was
no significant difference between the untreated and anti-
ST2 mAb-treated groups. Compared with the noninfected
mice, the eosinophil percentage was significantly increased
in the A. cantonensis-infected group (p < 0.01). When theFigure 1. Eosinophil percentage in differential white blood
cell counts was decreased when Angiostrongylus cantonensis-
infected mice received the injections of anti-ST2 monoclonal
antibody (mAb). The blood samples were collected every
week for thin blood smear. N Z noninfected group; Ac Z A.
cantonensis-infected group; each mouse was orally infected
with 35 infectious larvae. þanti-ST2 Z mice received in-
jections of anti-ST2 mAb (50 mg) 3 days postinfection and
subsequent booster injections of the same dose at 5-day in-
tervals. Data are presented as mean  standard deviation;
n Z 10. * Significantly increased, related to the N group,
p < 0.01. ** Significantly decreased, related to the Ac group,
p < 0.01.infected mice were injected with anti-ST2 mAb, the
eosinophil percentage was significantly decreased at 14
dpi, 21 dpi, and 28 dpi (p < 0.01).
The levels of IgE in the sera
The levels of IgE in the sera were analyzed every week in
each group after the infection (Fig. 2). In noninfected mice,
there was no significant difference between the untreated
and anti-ST2 mAb-treated groups.
Mice that were infected with A. cantonensis had levels
of IgE that were significantly increased with or without anti-
ST2 mAb injection from the 1st week after the infection
(p < 0.01). However, the levels of IgE significantly
decreased in the mAb-injected group at the 7 dpi and 14 dpi
(p < 0.01).
Expression of cytokines
The expression levels of various cytokines were all deter-
mined by ELISA. In A. cantonensis-infected mice, the levels
of IL-5 significantly increased at 14 dpi, 21 dpi, and 28 dpi
(p < 0.01), and then significantly decreased when the
infected mice were injected with anti-ST2 mAb (Fig. 3).
The levels of IFN-g and IL-4 in all groups were very low
and nearly undetectable.
Pathological examinations
Dilatation of the skull and softening of the cranial bone
were observed macroscopically in A. cantonensis-infected
mice at 14 dpi, 21 dpi, 28 dpi, and 35 dpi with or without
treatment. The sections of all infected groups revealed0
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Figure 2. The levels of immunoglobulin E (IgE) were signifi-
cantly increased in Angiostrongylus cantonensis-infected and
anti-ST2 monoclonal antibody (mAb)-injected mice. The serum
samples from each group (10 mice) were collected every week
and pooled for enzyme-linked immunosorbent assay.
N Z noninfected group; Ac Z A. cantonensis-infected group;
each mouse was orally infected with 35 infectious larvae.
þanti-ST2Z infected mice received injections of anti-ST2 mAb
(50 mg) at 3 days postinfection and subsequent booster in-
jections of the same dose at 5-day intervals. Data are pre-
sented as mean  standard deviation and are representative of
two independent experiments. * Significantly decreased,
related to the Ac group, p < 0.01.
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Figure 3. Anti-ST2 monoclonal antibody (mAb) reduces the
expressions of interleukin-5 (IL-5) in the blood of Angios-
trongylus cantonensis-infected mice. The serum samples from
each group (10 mice) were collected every week and pooled for
enzyme-linked immunosorbent assay. N Z noninfected group;
Ac Z A. cantonensis-infected group; each mouse was orally
infected with 35 infectious larvae. þanti-ST2 Z infected mice
received injections of anti-ST2 mAb (50 mg) at 3 days post-
infection and subsequent booster injections of the same dose
at 5-day intervals. Data are presented as mean  standard
deviation and are representative of two independent experi-
ments. * Significantly increased, related to the N group,
p < 0.01. ** Significantly decreased, related to the Ac group,
p < 0.01.
94 C.-C. Chuang et al.hemorrhage and traumatic lesions caused by migrating
larvae in the parenchyma of the brains.
The average width of the meninges in normal mice was
approximately 3 mm (Fig. 4A). There was no infiltration of
inflammatory cells in noninfected mice that were treated
with anti-ST2 mAb (Fig. 4B).
In A. cantonensis-infected mice, meningitis with the
infiltration of a large number of inflammatory cells was
observed in untreated (Fig. 4C and D) and mAb-injected
mice (Fig. 4E and F) at 21 dpi. The average width of the
meninges in 10 fields was 51.22  6.61 mm in the untreated
group and 53.33  4.71 mm in the mAb-injected group. The
percentage of eosinophil in infiltrated cells was
63.33%  4.78% in the untreated group and 39.0%  3.56% in
the mAb-injected group. Meningeal infiltration of eosino-
phils was significantly reduced (p < 0.01).Discussion
The accumulation and activation of eosinophils in the brain
is an important hallmark of A. cantonensis infection in both
humans and mice.6,26 IL-5, a Th2-type cytokine, enhances
the maturation and survival of eosinophil,15,27 and is
essential in the orchestration of eosinophil-associated
inflammation. Exogenous IL-33 enhances the expression of
IL-5 in noninfected and A. cantonensis-infected mice.23 It is
believed that both IL-5 and IL-33 play crucial roles in the
pathogenesis of angiostrongylosis. Reducing the expressions
of IL-5 and IL-33 is also a useful approach to treat
angiostrongylosis.6,23
According to our study, the expression of IL-5 obviously
increased in A. cantonensis-infected C57BL/six mice.
However, it decreased in anti-ST2 mAb-injected mice. IL-33could mediate the expression of IL-5 by signaling through
ST2 receptor in angiostrongylosis.
IL-33 enhances the production of IgE in allergic diseases
and is a requisite for IL-13-driven Type 2 responses during
hookworm infection.28,29 The level of IgE increased in mice
when mice were infected with A. cantonensis. Thus, the
role of IgE in angiostrongylosis is uncertain. In A. canto-
nensis-infected mice that were treated with anti-ST2 mAb,
the expression of IgE may still be enhanced even though the
level of IL-5 was significantly lower than that in untreated
mice. IgE seems to be enhanced through a mechanism
mediated by IL-5 rather than by IL-33. The expression of IgE
at the 1st week and 2nd week after the infection signifi-
cantly decreased. Blocking of IL-33 by anti-ST2 mAb could
delay the production of IgE.
ST2 is a transmembrane glycoprotein in the IL-1 receptor
family. This receptor is expressed on various types of cells,
including epithelial cells, mast cells, fibroblasts, eosino-
phils, and Th2 lymphocytes.30,31 Eosinophils seem to be the
direct target leukocyte for IL-33 but not neutrophils. IL-33
induces adhesion and CD11b expression and enhances sur-
vival of eosinophils.32,33 In vivo treatment with IL-33 leads
to eosinophilia in A. cantonensis-infected mice.8 It has
been demonstrated that anti-IL-33 mAb could prevent the
pathological development of asthma in a mouse model.34
In our study, the percentage of eosinophil in white blood
cells increased in A. cantonensis-infected mice. However,
the percentage significantly decreased when the infected
mice received anti-ST2 mAb injections. According to the
pathological examinations, eosinophilic meningitis was
noticed in A. cantonensis-infected mice. The injection of
anti-ST2 mAb did not alter the severity of meningitis. This
could be because the amount of mAb injected in our study
is not enough to reduce the immunopathology, or because
the antibody is not functional. More tests are necessary to
determine the function and appropriate dose for the
injected antibody. However, the proportions of cell types in
the treated and untreated groups were different. Menin-
geal infiltration of eosinophils in anti-ST2 mAb-treated mice
was markedly reduced. The IL-33/ST2 axis may play an
important role in eosinophil expansion in A. cantonensis
infection.
In addition to eosinophils, lymphocytes, plasma cells,
and other inflammatory cells are also infiltrated into the
meninges, but more detailed studies are needed to deter-
mine the types and ratios of these infiltrated cells in un-
treated and mAb-treated mice.
IL-33 has been shown to modulate intestinal nematode
expulsion by inducing the Th2 adaptive response.35 Eosin-
ophils are able to release some granules for killing the
larvae, and have been thought to be responsible for innate
resistance in nonpermissive hosts in angiostrongylosis.6
More tests are necessary to determine the larvae recovery
and prognosis of A. cantonensis-infected mice that are
treated with anti-ST2 mAb.
In conclusion, the results of this study show that
blockage of IL-33 signaling by anti-ST2 mAb could decrease
the expression of IL-5, delay the production of IgE, and
reduce the infiltration eosinophils. The IL-33/ST2 axis may
play a crucial role in the pathogenesis of angiostrongylosis,
and could be useful for the development of strategies to
reduce the neurological damage caused by this infection.
Figure 4. Histopathological examinations in the brains of mice. All the mice were sacrificed at 21 days postinfection. There was
no inflammatory response in (A) noninfected mice and (B) those treated with anti-ST2 monoclonal antibody (mAb). (C,D) Sections
showing meningitis with eosinophilic infiltration (arrows) in Angiostrongylus cantonensis-infected mice and (E,F) those treated with
anti-ST2 mAb.
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